Open Veils · Answer
Why is melatonin unavailable in the uk?
The official rationale — that melatonin 'exerts significant modification to human physiology' — is real but selectively applied: dozens of far more potent hormones and compounds sit freely on UK pharmacy shelves. The prescription wall creates a structurally captive market for licensed pharmaceutical sleep products. No formal comparative assessment of international regulatory frameworks has ever been conducted by the Department, per a June 2026 Parliamentary written answer.
Evidence
- The MHRA's stated position, confirmed to Which? in February 2026, is that melatonin poses 'an identifiable risk to public/patient safety due to its ability to exert significant modification to human physiology.'
- Catherine Austin Fitts' framework of 'agency capture' is instructive here: regulatory bodies tend to serve the interests of the industries they nominally oversee.
- Richard Werner's analysis of regulatory asymmetry applies equally to medicines: classification decisions follow incentive structures, not pure safety science.
- A June 2026 Parliamentary written answer confirmed the Department has never conducted a formal assessment comparing UK classification with other countries' frameworks.
- Yet Jack Kruse and other circadian-biology researchers have long argued melatonin is among the most benign endogenous hormones humans produce — the body synthesises it nightly without incident.
